Physician
Michigan Primary Care Partners P C
Michigan Primary Care Partners P C was paid $4.35M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoMICHIGAN PRIMARY CARE PARTNERS P C
BIG RAPIDS, MI 49307
BIG RAPIDS, MI 49307
33aNPI1366497380assigned 05/24/2006
33bProvider typeAnesthesiology Physician
28Total paid$4.35M
24GClaims102,290
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Michigan
Rank by total paid#8 of 85
Median peer was paid$103K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,894 | $556K | |
| 2019 | 10,973 | $453K | |
| 2020 | 9,293 | $441K | |
| 2021 | 11,926 | $593K | |
| 2022 | 16,193 | $779K | |
| 2023 | 15,216 | $841K | |
| 2024incomplete | 24,795 | $687K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 26,085 | 24,188 | $1.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 22,116 | 20,150 | $1.01M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.6% | 2,550 | 2,522 | $242K |
| 64483 | 4.0% | 2,207 | 2,184 | $173K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.4% | 1,570 | 1,552 | $149K |
| 64635 | 3.4% | 966 | 952 | $148K | |
| 64493 | 3.1% | 2,161 | 2,059 | $137K | |
| 99490 | Ccm add 20min | 2.4% | 4,161 | 4,146 | $106K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.3% | 1,149 | 1,135 | $102K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 1,445 | 1,439 | $94K |
| 64636 | 1.8% | 1,891 | 900 | $78K | |
| 64494 | 1.6% | 2,067 | 1,939 | $69K |
73 more codes
| 01936 | 1.3% | 1,123 | $58K | |
| 64490 | 1.2% | 803 | $52K | |
| 95886 | <1% | 613 | $34K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 670 | $27K |
| 64491 | <1% | 768 | $25K | |
| 99457 | <1% | 968 | $21K | |
| 64495 | <1% | 516 | $19K | |
| 99439 | <1% | 571 | $15K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,692 | $12K |
| 99442 | <1% | 348 | $12K | |
| 20611 | <1% | 231 | $8K | |
| 76942 | <1% | 335 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,158 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,475 | $6K |
| 96127 | <1% | 2,071 | $6K | |
| 64484 | <1% | 173 | $5K | |
| 64492 | <1% | 134 | $5K | |
| 62321 | <1% | 86 | $4K | |
| 99152 | <1% | 545 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 141 | $4K |
| 99454 | <1% | 210 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 154 | $4K |
| G9007 | Coordinated care fee, scheduled team conference | <1% | 203 | $4K |
| 99495 | <1% | 49 | $4K | |
| 27096 | <1% | 123 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 33 | $4K |
| 90686 | <1% | 159 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 53 | $2K |
| G9002 | Coordinated care fee, maintenance rate | <1% | 46 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,345 | $2K |
| 99458 | <1% | 140 | $2K | |
| 81002 | <1% | 798 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 199 | $2K |
| 20610 | <1% | 124 | $2K | |
| 99441 | <1% | 58 | $1K | |
| 20553 | <1% | 60 | $1K | |
| 01992 | <1% | 24 | $977.20 | |
| 98966 | <1% | 372 | $906.84 | |
| 95909 | <1% | 15 | $863.15 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,496 | $830.18 |
| 90658 | <1% | 68 | $693.57 | |
| 90674 | <1% | 30 | $683.39 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 28 | $661.33 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 485 | $641.80 |
| 93000 | <1% | 67 | $523.60 | |
| 99426 | <1% | 15 | $477.92 | |
| G0008 | Administration of influenza virus vaccine | <1% | 100 | $469.70 |
| 0011A | <1% | 12 | $431.80 | |
| 99406 | <1% | 60 | $357.48 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 30 | $350.07 |
| 20552 | <1% | 12 | $223.02 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 47 | $167.45 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 16 | $166.78 |
| 99453 | <1% | 27 | $164.40 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $144.04 |
| J3490 | Unclassified drugs | <1% | 20 | $131.26 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 38 | $107.83 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 19 | $93.46 |
| 81025 | <1% | 14 | $91.62 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | <1% | 56 | $89.00 |
| 3078F | <1% | 3,642 | $3.81 | |
| 3074F | <1% | 3,921 | $3.57 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 326 | $2.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 49 | $2.88 |
| 3079F | <1% | 2,176 | $2.72 | |
| 3075F | <1% | 1,523 | $2.32 | |
| 3077F | <1% | 652 | $1.01 | |
| 3080F | <1% | 282 | $0.39 | |
| 1160F | 0% | 15 | $0.00 | |
| 1111F | 0% | 26 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 36 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 22 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJUNEJA, GIRISH (OWNER)
| Provider | Location | Paid |
|---|---|---|
| West Michigan Surgery Center, LLC | Big Rapids, MI | $844K |
| West Michigan Pain Center PC | Grand Rapids, MI | $78K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.